All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

57

Reset

57 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IanalumabVAY736, VAY736 AIPhase 318 trials

    Novartis · Primary Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus, Sjogren Syndrome

  • GlucocorticoidsPhase 37 trials

    Novartis · VEXAS Syndrome, ANCA Associated Vasculitis (AAV), Anti-Glomerular Basement Membrane Disease

  • PelacarsenTQJ230Phase 37 trials

    Novartis · Cardiovascular Disease and Lipoprotein(a), Atherosclerotic Cardiovascular Disease (ASCVD), Atherosclerotic Cardiovascular Disease

  • FUB523zigakibart, BION-1301Phase 36 trials

    Novartis · IgA Nephropathy, Immunoglobulin A Nephropathy, IgA Nephropathy (IgAN)

  • PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease

  • KLU156Phase 34 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria

  • PelabresibDAK539, CPI-0610Phase 34 trials

    Novartis · Myelofibrosis, Primary Myelofibrosis, Primary Myelofibrosis (PMF)

  • 177Lu-PSMA-617Lutetium [177Lu] vipivotide tetraxetan, lutetium vipivotide tetraxetanPhase 33 trials

    Novartis · Prostatic Neoplasms, Prostatic Neoplasm, Metastatic Castration Resistant Prostate Cancer (mCRPC)

  • AbelacimabMAA868Phase 33 trials

    Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke

  • PacibekitugTOUR006, PAC001Phase 33 trials

    Tourmaline Bio, Inc., a Novartis Company · Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases

  • [68Ga]Ga-DOTA-TATEAAA501Phase 32 trials

    Novartis · Extensive Stage Small Cell Lung Cancer, Neuroendocrine Neoplasms

  • AAA817[225Ac]Ac-PSMA-617Phase 32 trials

    Novartis · Prostate Cancer

  • ARDTPhase 32 trials

    Novartis · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostatic Neoplasms

  • ARPI: EnzalutamideARPI abirateronePhase 32 trials

    Novartis · Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer

  • NaporafenibLXH254, ERAS-254Phase 32 trials

    Novartis · Melanoma, Advanced or Metastatic NRAS-mutant Melanoma

  • QMF149Phase 31 trial

    Novartis · Asthma

  • QVM149Phase 31 trial

    Novartis · Asthma

  • rapcabtagene autoleucelYTB323Phase 28 trials

    Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)

  • KAE609CipargaminPhase 25 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria, Severe Malaria

  • luxdegalutamideJSB462, ARV-766Phase 24 trials

    Novartis · Prostatic Cancer, Castration-Resistant, Progressive Metastatic Castrate Resistant Prostate Cancer, Prostate Cancer Metastatic

  • MAS825ArumakimigPhase 24 trials

    Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome

  • DDY391Phase 23 trials

    Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease

  • GIA632Phase 23 trials

    Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus

  • INE963Phase 23 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria

  • JDQ443OpnurasibPhase 23 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation, Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation

  • QCZ484Phase 23 trials

    Novartis · Hypertension (HTN), Hypertension, Hypercholesterolaemia

  • TulmimetostatDZR123, Tulmimetostat DL1Phase 23 trials

    Novartis · Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Advanced Solid Tumor

  • [177Lu]Lu-NeoBLutetium NeoB, [177Lu]-NeoBPhase 22 trials

    Novartis · Breast Cancer, Neoplasms

  • [68Ga]Ga-NeoBGallium NeoB, [68Ga]-NeoBPhase 22 trials

    Novartis · Breast Cancer, Neoplasms

  • DFV890Phase 22 trials

    Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis

  • TNO155Phase 22 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors

  • VHB937Phase 22 trials

    Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease

  • AMO959BY1298, BY101298Phase 21 trial

    Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

  • CPK850Phase 21 trial

    Novartis · Retinitis Pigmentosa

  • DII235Phase 21 trial

    Novartis · Lipoprotein Disorder

  • DJI136Phase 21 trial

    Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)

  • DYP688Phase 21 trial

    Novartis · Metastatic Uveal Melanoma

  • ECI830Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer

  • EDI048Phase 21 trial

    Novartis · Cryptosporidiosis

  • EYU688Phase 21 trial

    Novartis · Dengue

  • FWY003Phase 21 trial

    Novartis · Geographic Atrophy Secondary to Age-related Macular Degeneration

  • GHZ339Phase 21 trial

    Novartis · Atopic Dermatitis

  • GVV858Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer

  • GXV813Phase 21 trial

    Novartis · Schizophrenia

  • iscalimabCFZ533Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • ITU512Phase 21 trial

    Novartis · Sickle Cell Disease

  • LTT462Phase 21 trial

    Novartis · Melanoma

  • LXE408Phase 21 trial

    Novartis · Chagas Disease

  • LYS006Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • NazartinibEGF816Phase 21 trial

    Novartis · Advanced Solid Tumors Which Are cMET-dependent

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.